Novel IMP-1 metallo-β-lactamase inhibitors can reverse meropenem resistance in Escherichia coli expressing IMP-1

被引:27
作者
Moloughney, JG [1 ]
Thomas, JD [1 ]
Toney, JH [1 ]
机构
[1] Montclair State Univ, Dept Chem & Biochem, Montclair, NJ 07043 USA
关键词
antibiotic resistance; beta-lactam antibiotics; metallo-beta-lactamase; metallo-beta-lactamase inhibitors; succinic acids;
D O I
10.1016/j.femsle.2004.11.042
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
IMP-1 metallo-beta-lactamase is a zinc metalloenzyme that confers antibiotic resistance to bacteria through the hydrolysis of beta-lactam antibiotics. Pathogens that express the enzyme show reduced susceptibility to carbapenems, Such as meropenem and imipenem. In order to identify novel IMP-1 inhibitors, the National Cancer Institute (NCI) chemical diversity set was screened using 96-well high throughput screening format. The collection yielded several novel succinic acid derivatives that exhibited mixed inhibition of IMP-1 with compound 20707 having the highest affinity with a K-i value of 3.3 muM +/- 1.7. The compounds are moderately potent inhibitors of IMP-1 with IC50 values ranging from 5.0 to 17 muM. An original chemical class of IMP-1 inhibitor, 2-((E)-(1,3-dihydroxy-2-methylpropan-2-ylimino)methyl)-4,6-diiodophenol, was discovered and was the most potent with an IC50 of 1.2 muM. NCI compounds, 20707, 140905 and 9746 sensitized a carbapenem-resistant laboratory strain of Escherichia coli to clinically achievable levels of meropenem. (C) 2004 Federation of European Microbiological Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:65 / 71
页数:7
相关论文
共 30 条
[2]  
Arakawa Y, 2000, J CLIN MICROBIOL, V38, P40
[3]   A NOVEL INTEGRON-LIKE ELEMENT CARRYING THE METALLO-BETA-LACTAMASE GENE BLA(IMP) [J].
ARAKAWA, Y ;
MURAKAMI, M ;
SUZUKI, K ;
ITO, H ;
WACHAROTAYANKUN, R ;
OHSUKA, S ;
KATO, N ;
OHTA, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (07) :1612-1615
[4]   IMP-4, a novel metallo-β-lactamase from nosocomial Acinetobacter spp. collected in Hong Kong between 1994 and 1998 [J].
Chu, YW ;
Afzal-Shah, M ;
Houang, ETS ;
Palepou, MFI ;
Lyon, DJ ;
Woodford, N ;
Livermore, DM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (03) :710-714
[5]  
Da Silva GJ, 2002, FEMS MICROBIOL LETT, V215, P33, DOI 10.1111/j.1574-6968.2002.tb11366.x
[6]   IMP-12, a new plasmid-encoded metallo-β-lactamase from a Pseudomonas putida clinical isolate [J].
Docquier, JD ;
Riccio, ML ;
Mugnaioli, C ;
Luzzaro, F ;
Endimiani, A ;
Toniolo, A ;
Amicosante, G ;
Rossolini, GM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (05) :1522-1528
[7]   Standard numbering scheme for class B β-lactamases [J].
Galleni, M ;
Lamotte-Brasseur, J ;
Rossolini, GM ;
Spencer, J ;
Dideberg, O ;
Frère, JM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (03) :660-663
[8]   Nosocomial outbreak of carbapenem-resistant Pseudomonas aeruginosa with a new blaIMP allele, blaIMP-7 [J].
Gibb, AP ;
Tribuddharat, C ;
Moore, RA ;
Louie, TJ ;
Krulicki, W ;
Livermore, DM ;
Palepou, MFI .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (01) :255-258
[9]   Inhibition of the metallo-beta-lactamase produced from Serratia marcescens by thiol compounds [J].
Goto, M ;
Takahashi, T ;
Yamashita, F ;
Koreeda, A ;
Mori, H ;
Ohta, M ;
Arakawa, Y .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 1997, 20 (11) :1136-1140
[10]   Synthesis and sar of thioester and thiol inhibitors of IMP-1 metallo-β-lactamase [J].
Greenlee, ML ;
Laub, JB ;
Balkovec, JM ;
Hammond, ML ;
Hammond, GG ;
Pompliano, DL ;
Epstein-Toney, JH .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (17) :2549-2554